Over 90 firms are actively involved in providing in silico services for drug discovery {{}}}

Presently, in silico tools / approaches are available for the identification, selection and optimization of pharmacological leads. in fact, the predictive power of such solutions has been demonstrated to enable researchers to bypass the traditional experimental screening of billions of molecules against hundreds of biological targets, thereby, allowing significant reductions in the investment of both time and resources.
 
To order this 290+ page report, which features 120+ figures and 135+ tables, please visit this link
 
The USD 124 million (by 2030) financial opportunity within the in silico drug discovery market for large molecules has been analyzed across the following segments:
Key Drug Discovery Steps
Target Identification
Target Validation
Hit Generation
Hit-to-Lead
Lead Optimization 
Type of Large Molecule
  • Antibodies
  • Proteins
  • Peptides
  • Nucleic Acids
  • Vectors
  • Company Size
  • Small
  • Mid-sized
  • Large

Target therapeutic Area
Autoimmune Disorders
Blood Disorders
Cardiovascular Disorders
Gastrointestinal and Digestive Disorders
Hormonal Disorders
Human Immunodeficiency Virus (HIV) / Acquired Immunodeficiency Syndrome (AIDS)
Infectious Diseases
Metabolic Disorders
Mental Disorders
Musculoskeletal Disorders
Neurological Disorders
Oncological Disorders
Respiratory Disorders
Skin Disorders
Urogenital Disorders
Others
Type of Sponsor
Industry Players
Non-Industry Players
Key Geographical Regions
North America
Europe
Asia-Pacific
 
The In Silico / Computer-Aided Drug Discovery Services Market: Focus on Large Molecules, 2020-2030, report features the following companies, which we identified to be key players in this domain: 

Abzena

BioDuro

BioNTech

ChemPartner

Creative Biostructure

GenScript

LakePharma

Sundia MediTech

Sygnature Discovery

Viva Biotech

 
Table of Contents
 
1. Preface

2. Executive Summary

3. Introduction


4. Market Landscape


5. Key Insights


6. Company Profiles


7. Company Competitiveness Analysis


8. Key Opportunity Areas


9. Emerging Business Models and Strategies 


10. Case study: comparison of drug discovery processes of small molecules     and large molecules


11. Survey insights


12. Cost saving analysis


13. Market Forecast 


14. In silico tools and upcoming trends in drug discovery
15. Executive Insights
16. Appendix 1: Tabulated Data
17. Appendix 2: List of Companies and Organizations
 
18. Appendix 3: Non-Computational Methods for Drug Discovery
 
To purchase a copy, please visit https://www.rootsanalysis.com/reports/view_document/in-silico-drug-discovery/298.html
 
Contact Details
Gaurav Chaudhary
+1 (415) 800 3415
 [email protected]

You may also like

Discussion

No comments yet... Be the first to leave a reply! Login here

avatar
BenJ
0 Karma
1320 Posts

Made with by Mamby